JHLT: The Podcast

ISHLT
  • 0.0 (0)
  • CIENCIAS DE LA VIDA
  • CADA MES

The Journal of Heart and Lung Transplantation podcast airs each month and features the JHLT Digital Media Editors in round table talks with the Journal's contributors.

  1. Episode 81: Lung Cancer after Lung Transplant

    1 ABR

    Episode 81: Lung Cancer after Lung Transplant

    JHLT: The Podcast kicks off April with a discussion of the paper, "Lung Cancer After Lung Transplantation: Early Detection and Curative Surgery Drive Long-Term Survival," which appears in the April issue of JHLT. Senior author Pauline Pradère, MD, of Hôpital Marie Lannelongue in Paris, joins the episode to talk about the paper. The conversation includes discussion of: The overall survival of patients who develop lung cancer after lung transplant—and the key differences between the cohort of patients who developed cancer versus the patients who did not Managing lung cancer in transplant recipients Immunosuppression in these patients, and other potential changes to clinical practice derived from the study For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt. Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

    14 min
  2. Episode 80: Solid Organ Transplantation and HIV Infection

    18 MAR

    Episode 80: Solid Organ Transplantation and HIV Infection

    JHLT: The Podcast continues a themed month on HIV infection in solid organ transplant, building on our last episode's exploration from Dr. Saeed at Montefiore in New York. Our guest this episode is infectious diseases expert Cameron Wolfe, MD, Professor of Medicine at Duke University Medical Center. He joined us while on sabbatical with his family in Brisbane Australia for a conversation about how transplant centers now consider HIV infection, including transplant recipients who are HIV positive. The discussion explores: How the HOPE Act of 2013 changed practice in the United States, and how other countries have handled HIV transplantation regulations Immunosuppresion, antiviral therapy, and opportunistic infection in HIV+ transplant recipients Whether organ-specific surveillance changes in HIV+ patients The ethics of using organs from HIV+ donors and ensuring HIV+ patients are treated equitably For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.

    18 min
  3. Episode 79: Early Experience in Heart Transplantation Using Donors with HIV

    4 MAR

    Episode 79: Early Experience in Heart Transplantation Using Donors with HIV

    This month on JHLT: The Podcast, the Digital Media Editors host two themed discussions around HIV in solid organ transplantation. The conversation begins with a discussion of the paper, "Early experience in heart transplantation utilizing donors with HIV," which appears in the March issue of JHLT. First author Omar Saeed, MD, MSc, of the Division of Cardiology at Montefiore Medical Center in New York, NY USA, joins the episode. The conversation includes discussion of: The ethics and evolution of the Montefiore program's transplant eligibility and criteria The role of the HOPE Act in the changes to the program Superinfection, viral strain analysis, and informed consent of organ recipients Long-term patient follow upsa nd how other centers can begin this research For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt. Return later this month for a broader conversation with an infectious diseases expert about HIV in transplantation. Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

    19 min
  4. Episode 78: Barriers and Opportunities in DCD Heart Transplantation

    18 FEB

    Episode 78: Barriers and Opportunities in DCD Heart Transplantation

    JHLT: The Podcast returns with an episode  for our heart transplant colleagues, discussing the paper, "Barriers and opportunities in donation after circulatory death heart transplantation," from the February issue of JHLT. Featured on this episode is first author, Katherine G. Phillips, MD, of the Department of Cardiothoracic Surgery at NYU Langone, and co-author, Brian Wayda, MD, from the Division of Cardiology at NYU Langone. The discussion explores: Geographic variability on DCD heart utilization—why it happens and how to address Concerns around donor progression to circulatory arrest after life support withdrawal The volume of DCD hearts not utilized each year—and the gap between those successfully transplanted For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt. Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

    12 min
  5. Episode 77: ISHLT Consensus Statement: Short Telomere Syndrome and Lung Transplantation

    4 FEB

    Episode 77: ISHLT Consensus Statement: Short Telomere Syndrome and Lung Transplantation

    In this episode of JHLT: The Podcast, the Digital Media Editors host a discussion on a new consensus statement from ISHLT on Short Telomere Syndrome (STS) and Lung Transplantation. The document was first published last month. They're joined by document leads Andrew Courtwright, MD, PhD, of the University of Pennsylvania in Philadelphia; Dr. John Mackintosh of Prince Charles Hospital in Brisbane; and John McDyer, MD, of the University of Pittsburgh Medical Center in Pittsburgh. The conversation includes discussion of: Recommendations for assessing patients for STS Which patients we should screen How the diagnosis influences transplant decision making and risk assessment How STS impacts immunosuppression Extrapulmonary comorbidities Future areas for research ISHLT Standards, Guidelines, and Consensus Statements are open to all at ISHLT.org. For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt. Return later this month for a conversation on barriers and opportunities in utilizing DCD hearts in transplantation. Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

    22 min
  6. Episode 76: Evolocumab's Impact on Coronary Physiology and Microstructure in De Novo Heart Transplant Recipients

    21 ENE

    Episode 76: Evolocumab's Impact on Coronary Physiology and Microstructure in De Novo Heart Transplant Recipients

    JHLT: The Podcast returns with an episode discussing the paper, "Impact of evolocumab on coronary physiology and microstructure in de-novo heart transplant recipients," from the January issue of JHLT. Featured on this episode is early career guest host Bin Yang, MD, of Massachusetts General Hospital. Mentored by Digital Media Editor Van-Khue Ton, MD, PhD, Dr. Yang shares hosting duties this episode and brings great questions to the discussion. Drs. Yang and Ton are joined by the first author, Salma Karim, and senior author, Hans Eiskjaer, both from Aarhus University Hospital in Denmark. The discussion explores: What imaging and physical markers the researchers used to determine if evolocumab was influencing the development of cardiac allograft vasculopathy (CAV) The potential role of lipid-lowering therapies or statins in treating CAV The relationship between CAV and microvascular resistance (IMR) For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt. In case you missed it, earlier this month the JHLT Digital Media Editors recapped their favorite papers from 2025. Take a listen! Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

    19 min
  7. Episode 75: A Look Back on 2025 in JHLT

    7 ENE

    Episode 75: A Look Back on 2025 in JHLT

    Happy new year and welcome to a new season of JHLT: The Podcast! In this year-end recap, the Digital Media Editors will each share one of their favorite studies from The Journal of Heart and Lung Transplantation in 2025. You'll get a look at some of the best science in advanced heart and lung failure from the past year.   Studies featured: Efficacy and safety of sotatercept across ranges of cardiac index in patients with pulmonary arterial hypertension: A pooled analysis of PULSAR and STELLAR Gomberg-Maitland M, et al. JHLT Apr 2025 44(4):609 – 624. A consensus-based framework for the psychosocial evaluation of pediatric candidates for cardiothoracic transplant and ventricular assist devices Lefkowitz DS, et al. JHLT Apr 2025 44(4):487-502. ABO-incompatible heart transplants in children aged 2-9 years: A new paradigm in transplant? Hollis P, et al. JHLT Dec 2025 44(12):1910-1917. Heart transplantation in Ukraine during wartime: A retrospective cohort study of standard vs marginal donor heart transplantation outcomes Todurov B, et al. JHLT Nov 2025 44(11):1728-1734.   For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.   Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

    14 min
  8. Episode 74: Outcomes for CTEPH patients with High Antiphospholipid Antibodies after Pulmonary Endarterectomy

    17/12/2025

    Episode 74: Outcomes for CTEPH patients with High Antiphospholipid Antibodies after Pulmonary Endarterectomy

    JHLT: The Podcast returns with an episode discussing the paper, "High Antiphospholipid Antibody Titers and Outcomes of Pulmonary Endarterectomy: A Single-Center Retrospective Observational Cohort Study," from the December issue of JHLT.   They are joined by the first author, Camille Miard, MD, and senior author, François Stéphan, MD, PhD, both from the cardiothoracic intensive care unit at Hôpital Marie Lannelongue in Paris.   The discussion explores: Whether antiphospholipid antibody titers could predict postoperative outcomes for CTEPH patients undergoing pulmonary endarterectomy (PEA) How APS patients differed from non-APS patients in the PEA cohort The changes in clinical practice at Marie Lannelongue after the study's findings   For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt.   Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

    11 min
Ver todo (82)

Acerca de

The Journal of Heart and Lung Transplantation podcast airs each month and features the JHLT Digital Media Editors in round table talks with the Journal's contributors.

Información

  • Creador
    ISHLT
  • Años de actividad
    2021 - 2026
  • Episodios
    82
  • Clasificación
    Apto
  • Mostrar sitio web
    JHLT: The Podcast

También te podría interesar